US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

66.97

-0.0976-0.15%

Post-market: 66.97-0.0055-0.01%16:10 EDT

Volume:215

Turnover:14.38K

Market Cap:669.77K

PE:- -

High:66.97

Open:66.84

Low:66.84

Close:67.07

52wk High:85.03

52wk Low:55.75

Shares:10.00K

Float Shares:10.00K

Volume Ratio:1.19

T/O Rate:2.15%

Dividend:2.08

Dividend Rate:3.10%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK's $10.6 Billion Acquisition of Nuvalent Bolsters Its Oncology Pipeline with Targeted Lung Cancer Drugs

Nuvalent to Be Acquired by GSK in Cash Deal

How a former lawyer is beating the stock market with these 11 picks

UBS Remains a Hold on GlaxoSmithKline (GSK)

Nuvalent Shares Leap Premarket on Takeover by GSK

GlaxoSmithKline (GSK) Gets a Sell from Barclays

GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent

GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

GSK paying 40% premium to boost the cancer business it previously unwound

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Dow Jones Top Company Headlines at 3 AM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | University ...

GSK to buy Nuvalent in $10.6bn deal to fast-track lung cancer push

Why GSK May Acquire Nuvalent — Report Points to $9B+ Deal Talks

GlaxoSmithKline in Advanced Talks to Acquire Cancer Drug Developer Nuvalent for Up to $10 Billion

24H | Nuvalent Stock Soars 17% as GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn

Tiger Newspress

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live

GSK Boosts Treasury Stock with Latest Share Buyback Tranche

GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/GSKH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":66.9705,"timestamp":1789156800000,"preClose":67.0681,"halted":0,"volume":215,"hourTrading":{"tag":"盘后","latestPrice":66.965,"preClose":66.9705,"latestTime":"16:10 EDT","volume":6,"amount":401.823,"timestamp":1789157404575,"change":-0.0055,"changeRate":-0.000082,"amplitude":0},"delay":0,"changeRate":-0.0014552372886662945,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Closed","change":-0.0976,"latestTime":"09-11 16:00:00 EDT","open":66.84,"high":66.9705,"low":66.84,"amount":14383,"amplitude":0.001946,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":67.0681,"nav":66.980718,"aum":669874.160718,"dividendRate":0.031045,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":66.965,"preClose":66.9705,"latestTime":"16:10 EDT","volume":6,"amount":401.823,"timestamp":1789157404575,"change":-0.0055,"changeRate":-0.000082,"amplitude":0},"volumeRatio":1.194446,"impliedVol":0.3507,"impliedVolPercentile":0.9735},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.194446,"shares":10001,"dividePrice":2.0791,"high":66.9705,"amplitude":0.001946,"preClose":67.0681,"low":66.84,"week52Low":55.7526,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":66.9705,"eps":0,"divideRate":0.031045,"volume":215,"delay":0,"ttmEps":0,"open":66.84,"prevYearClose":68.2031,"prevWeekClose":69.5112,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":70.7456,"twentyDayClose":69.8223,"sixtyDayClose":72.7498},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1145540131","title":"GSK's $10.6 Billion Acquisition of Nuvalent Bolsters Its Oncology Pipeline with Targeted Lung Cancer Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1145540131","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145540131?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:03","pubTimestamp":1781006584,"startTime":"0","endTime":"0","summary":"British pharmaceutical giant GlaxoSmithKline PLC announced on Tuesday that it has reached an agreement to acquire U.S. biotech firm Nuvalent, Inc. for $10.6 billion. The news sent Nuvalent, Inc....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4139","GSKH","BK4532","BK4007","GSK","NUVL","LU1829250122.USD","BK4585","BK4539","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642462140","title":"Nuvalent to Be Acquired by GSK in Cash Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2642462140","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642462140?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:29","pubTimestamp":1781004551,"startTime":"0","endTime":"0","summary":"Nuvalent ( ($NUVL) ) has shared an update. On 9 June 2026, Nuvalent entered into a merger agreement under which GlaxoSmithKline will launch a tende...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvalent-to-be-acquired-by-gsk-in-cash-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvalent-to-be-acquired-by-gsk-in-cash-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","BK4539","NUVL","BK4139","GSKH","LU1829250122.USD","GSK","BK4532","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464581","title":"How a former lawyer is beating the stock market with these 11 picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464581","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464581?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:59","pubTimestamp":1781002740,"startTime":"0","endTime":"0","summary":"Alphabet and Mastercard are top holdings of this outperforming fund. Alphabet has a lot of winning businesses, says fund manager Tom Winmill.\"What we like to see in the numbers are a lot of free cash flow and then the ability of that company to reinvest free cash flow in order to get the compounding effect, and Alphabet has the ability to do so,\" he said, adding it has an \"unassailable advantage in growth.\" He favors Mastercard for many of the same reasons.\"They were basically investing in a business that was slowing down by buying back their stock, taking on debt. Those are bad signs,\" he said. \"And then they're going to lower-margin markets like expanding into Central and South America.\". \"They're growing, and they have a dynamic approach to pricing in the market,\" along with a solid history and focused management, he said of the insurer.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLZ","BRKD","GSKH","GGLL","MSFO","JPX","MSFU","MSFW","GOOP","MA","JPO","APLX","MSFY","BRKU","GSK","AZO","MSFX","APLD","GGLS","META","LU1988902786.USD","BULZ","GOOGL","BRK.B","LU0985489474.SGD","NUVL","BRKC","BRKW","WSM","JPMO","MSFD","TSLA","USJW.SI","MSFL","NVDA","GSK.UK","GOU","MAGY","GOOG","GOOW","LRCX","GOOY","MTN","AMZN","GOOX","PGR","MSFT","YMAG","LRCU","AAPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642469527","title":"UBS Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642469527","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642469527?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:45","pubTimestamp":1780998339,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of £19.40. According to TipRanks, Weston is a 4...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSK","GSK.UK","BK4585","LU1829250122.USD","UBS","LU3187612489.SGD","GSKH","BK4534","BK4532","LU1863844665.USD","IE0034235071.USD","BK4118","LU1863844749.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642664504","title":"Nuvalent Shares Leap Premarket on Takeover by GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2642664504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642664504?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:45","pubTimestamp":1780998300,"startTime":"0","endTime":"0","summary":"Shares of Nuvalent surged in premarket trading Tuesday after the clinical-stage biopharmaceutical company agreed to be acquired by U.K. pharmaceutical company GSK for $10.6 billion.GSK is paying $124 a share in cash for Nuvalent, a 40% premium to Monday's closing price of $88.49 for the Cambridge, Mass., company.The deal is slated to close in the third quarter.Nuvalent shares were recently up more than 38% to $122.51 in premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4139","BK4007","BK4532","BK4585","NUVL","BK4539","GSKH","GSK","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642466901","title":"GlaxoSmithKline (GSK) Gets a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2642466901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642466901?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:36","pubTimestamp":1780997770,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Sell rating on GlaxoSmithKline today and set a price target of £18.00. According to TipRanks, Gordon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","CFA","GSK","GSKH","LU1829250122.USD","BK4588","BK4585","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164747521","title":"GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=1164747521","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164747521?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:31","pubTimestamp":1780997497,"startTime":"0","endTime":"0","summary":"The British pharmaceutical giant GlaxoSmithKline PLC has finalized an agreement to acquire the US-based biopharmaceutical company Nuvalent, Inc. for a total of $10.6 billion, aiming to significantly...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","GSK.UK","NUVL","BK4532","LU1829250122.USD","GSK","BK4585","BK4139","BK4588","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642465642","title":"GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2642465642","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642465642?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:07","pubTimestamp":1780996020,"startTime":"0","endTime":"0","summary":"0906 GMT - The initial market reaction to GSK's $10.6 billion acquisition of cancer specialist Nuvalent points to some trepidation among investors about the size of the deal, AJ Bell's Russ Mould says. Nuvalent is the U.K. drugmaker's biggest acquisition in years and fits with its goal of turning oncology into a key growth engine for the group, Mould says. \"GSK is paying a hefty premium to get the deal over the line and the two big lung cancer products flagged by [GSK CEO Luke] Miels in heralding the takeover still await regulatory approval,\" Mould says. \"In rolling the dice on such a big transaction, he is undoubtedly taking a risk.\" GSK shares fall 3.3%. Nuvalent jumps 38% in U.S. premarket trading. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","NUVL","GSK","BK4585","BK4532","BK4139","BK4588","BK4539","BK4007","GSKH","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642463396","title":"Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2642463396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642463396?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:39","pubTimestamp":1780994340,"startTime":"0","endTime":"0","summary":"Under a new CEO, GSK makes a big bet on cancer drugs. GSK on Tuesday struck a deal to buy Nuvalent for $10.6 billion.U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.GSK last struck a deal of that size in the 2018 deal to buy Novartis out of its consumer healthcare joint venture that later would become Haleon. Novartis also was the counterparty in the complicated 2014 deal in which GSK swapped its oncology portfolio for the Swiss firm's vaccines business.Though it grew by 43% last year, oncology revenue only accounted for GBP2 billion  of GSK's GBP32.67 billion in revenue.Now, GSK is revving up its oncology business once again in buying the Boston company  for $124 per share in cash, a 40% premium to Monday's close in the first major move since new CEO Luke Miels took over the company.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE0002141913.USD","LU0208291251.USD","NUVL","BK4578","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0211331839.USD","LU0320765489.SGD","LU1829250122.USD","NVS","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4539","BK4585","IE00B4R5TH58.HKD","BK4532","BK4139","BK4007","GSK","GSK.UK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642450055","title":"GSK paying 40% premium to boost the cancer business it previously unwound","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450055","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450055?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:54","pubTimestamp":1780991640,"startTime":"0","endTime":"0","summary":"This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","LU1829250122.USD","BK4007","GSKH","BK4532","BK4588","GSK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642450699","title":"GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450699","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450699?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:37","pubTimestamp":1780990620,"startTime":"0","endTime":"0","summary":"GSK on Tuesday struck a deal to buy Nuvalent for $10.6 billion.U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.GSK last struck a deal of that size in the 2018 deal to buy Novartis out of its consumer healthcare joint venture that later would become Haleon. Novartis also was the counterparty in the complicated 2014 deal in which GSK swapped its oncology portfolio for the Swiss firm's vaccines business.Though it grew by 43% last year, oncology revenue only accounted for GBP2 billion  of GSK's GBP32.67 billion in revenue.Now, GSK is revving up its oncology business once again in buying the Boston company  for $124 per share in cash, a 40% premium to Monday's close in the first major move since new CEO Luke Miels took over the company.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009355771.USD","GSK.UK","BK4585","NUVL","GSKH","BK4532","IE00B4R5TH58.HKD","BK4588","IE00B2B36J28.USD","IE0002141913.USD","LU1829250122.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU0208291251.USD","BK4578","LU0211331839.USD","IE00BJT1NW94.SGD","NVS","BK4539","LU0070302665.USD","IE00BJJMRZ35.SGD","GSK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642457899","title":"Dow Jones Top Company Headlines at 3 AM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | University ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2642457899","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642457899?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:00","pubTimestamp":1780988400,"startTime":"0","endTime":"0","summary":"The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are under FDA review for approval this year.University Endowments Are About to Strike It Big on the SpaceX IPO. Some schools have a tenth or more of their endowments in Elon Musk's rocket company.OpenAI Files to Go Public in Test of Investor Appetite for Top AI Startups. The ChatGPT maker confidentially filed for an offering, but said 'it may be a while' before it goes public. U.S. Expands List of Chinese Tech Companies It Says Assist Beijing's Military. Some well-known companies were added to the annually updated list, which designates them as a U.S. national-security risk.Meta Launches 'Workforce Academy' to Train Workers to Build Data Centers. The five-week program, which is free of charge and guarantees a job, follows a recent layoff of 8,000 employees.Blackstone-Backed Data-Center Operator Taps Investors Ahead of Over $1.0 Billion Singapore IPO. AirTrunk, founded by Australian billi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","IE00BZ18W456.USD","BK4539","AM","YMAG","IE00BZ18W340.USD","BK4581","BK4007","GSK","IE00BMQBXF63.USD","BK4532","GSK.UK","BK4588","NUVL","ET","BK4139","BK4561","BK4144","LU1829250122.USD","GSKH","MAGY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642477452","title":"GSK to buy Nuvalent in $10.6bn deal to fast-track lung cancer push","url":"https://stock-news.laohu8.com/highlight/detail?id=2642477452","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642477452?lang=en_us&edition=fundamental","pubTime":"2026-06-09 14:30","pubTimestamp":1780986611,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has agreed to acquire Boston-based clinical-stage oncology specialist Nuvalent for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-to-buy-nuvalent-in-10-6bn-deal-to-fast-track-lung-cancer-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-to-buy-nuvalent-in-10-6bn-deal-to-fast-track-lung-cancer-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","NUVL","BK4539","GSK.UK","GSKH","LU1829250122.USD","BK4007","BK4532","GSK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642439454","title":"Why GSK May Acquire Nuvalent — Report Points to $9B+ Deal Talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2642439454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642439454?lang=en_us&edition=fundamental","pubTime":"2026-06-09 13:58","pubTimestamp":1780984695,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) is reportedly in talks to acquire cancer drugmaker Nuvalent ($NUVL). According to The Financial Times, citing people familia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-gsk-may-acquire-nuvalent-report-points-to-9b-deal-talks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-gsk-may-acquire-nuvalent-report-points-to-9b-deal-talks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","BK4139","BK4122","NUVL","BK4539","GSK","GSK.UK","PCOM","BK4585","LU1829250122.USD","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152613863","title":"GlaxoSmithKline in Advanced Talks to Acquire Cancer Drug Developer Nuvalent for Up to $10 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1152613863","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152613863?lang=en_us&edition=fundamental","pubTime":"2026-06-09 11:34","pubTimestamp":1780976086,"startTime":"0","endTime":"0","summary":"Reports indicate that GlaxoSmithKline PLC (GSK.US) is in advanced discussions to acquire cancer therapy company Nuvalent, Inc. (NUVL.US), with the deal valued between $9 billion and $10...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","GSK.UK","BK4139","BK4539","GSKH","LU1829250122.USD","BK4585","NUVL","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642262458","title":"24H | Nuvalent Stock Soars 17% as GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn","url":"https://stock-news.laohu8.com/highlight/detail?id=2642262458","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642262458?lang=en_us&edition=fundamental","pubTime":"2026-06-09 09:17","pubTimestamp":1780967831,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42G141:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","IE00B3T34201.USD","LU1046248800.SGD","LU0225283273.USD","NUVL","LU1202635105.USD","SG9999001176.SGD","LU0971552830.HKD","LU1228905037.USD","LU1983299246.USD","LU1302929846.USD","LU0971552673.USD","BK4139","SGXZ57979304.SGD","LU1481599808.USD","LU0306806265.USD","SG9999001176.USD","LU0557290698.USD","GSK","LU0203345920.USD","LU0109981661.USD","LU0289739699.SGD","LU0211331839.USD","LU2646069778.SGD","GSKH","IE0034235071.USD","LU0306807586.USD","LU0987226296.USD","LU1400636574.HKD","LU0225771236.USD","BK4539","LU0985481810.HKD","IE00BWDBJ516.SGD","LU0225284248.USD","LU0058720904.USD","LU1228905540.USD","LU0161305163.EUR","LU1064927863.SGD","LU2089984988.USD","SG9999013999.USD","LU1645745479.HKD","LU1098665638.USD","LU1015430645.USD","BK5011","IE00BQJZX424.USD","LU1481600234.SGD","LU1487256676.USD","LU1670756490.USD","LU0545562505.USD","LU1309081286.SGD","LU1400636657.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641438597","title":"European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2641438597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641438597?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:10","pubTimestamp":1780931424,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biotech firm Evaxion , which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago  and telecommunications company Nokia , which increased 4.4% and 1.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biopharmaceutical company Cellectis , which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi  and biopharmaceutical company Grifols , which were down 2% each.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals  and NuCana , which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP  and biopharmaceutical company Amarin , which ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0300736492.USD","SQNS","BK4505","LU1093756325.SGD","CLLS","BK4020","GSK","LU0320765646.SGD","GSKH","IE00BMPRXN33.USD","LU0300736062.USD","BK4532","BDRX","IE00BMPRXR70.SGD","LU0072461881.USD","AMRN","LU1093756168.USD","BK4585","LU1829250122.USD","AUTL","BK4139","LNOK","BK4141","BPH","NCNA","MREO","NVO","GSK.UK","NGG","NVOX","IE00BZ1G4Q59.USD","LU1162221912.USD","IE00BKVL7J92.USD","TRVG","BK4201","BK4588","NOK","BK4599","LU0006061336.USD","NVOH","GRFS","BK4547","LU0162691827.USD","SNY","EVAX","IE00BFXG1179.USD","BK4077","LU0154236417.USD","BK4208","BK4007","BP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641480300","title":"GSK Boosts Treasury Stock with Latest Share Buyback Tranche","url":"https://stock-news.laohu8.com/highlight/detail?id=2641480300","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641480300?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:02","pubTimestamp":1780927345,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has continued its existing share buyback programme, repurchasing more than 1.6 millio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-with-latest-share-buyback-tranche?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-with-latest-share-buyback-tranche?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4532","GSK","LU1829250122.USD","GSKH","BK4007","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641141238","title":"GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2641141238","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641141238?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:31","pubTimestamp":1780677068,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has completed a Phase 1 trial titled “A Phase 1, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-pneumococcal-shot-reaches-key-milestone-in-midlife-adult-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-pneumococcal-shot-reaches-key-milestone-in-midlife-adult-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","LU1829250122.USD","GSK","BK4588","GSKH","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640821661","title":"GlaxoSmithKline (GSK) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2640821661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640821661?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:25","pubTimestamp":1780521915,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on GlaxoSmithKline today and set a price target of £25.00. According to TipRanks, Leucht...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4588","BK4007","GSKH","GSK","LU1829250122.USD","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}